AffiAB® Goat anti-NSP1 (SARS-CoV-2) Polyclonal IgG Antibody is highly specific and offers 0.1% cross-reactivity. The antibody is suitable for ELISA, Western blot, and other assays, providing a reliable and accurate detection of NSP1 (SARS-CoV-2).
The AffiAB® Goat anti-NSP1 (SARS-CoV-2) Polyclonal IgG Antibody is an antibody specifically designed to target and detect the NSP1 protein of the SARS-CoV-2 virus. NSP1 (non-structural protein 1) is one of the key viral proteins encoded by the SARS-CoV-2 genome and plays a critical role in viral replication and immune evasion.
This polyclonal antibody is generated by immunizing goats with purified NSP1 protein or a specific peptide sequence derived from NSP1. The resulting antibody is then purified from goat serum using various purification techniques to ensure high specificity and quality.
The AffiAB® Goat anti-NSP1 (SARS-CoV-2) Polyclonal IgG Antibody is widely used in research and diagnostic applications to study the SARS-CoV-2 virus. It can be utilized in techniques such as Western blotting, immunohistochemistry, immunofluorescence, and ELISA to detect and analyze NSP1 protein expression in infected cells or patient samples.
By specifically recognizing NSP1, this antibody enables researchers to investigate the localization, expression levels, and functional roles of NSP1 during SARS-CoV-2 infection. This information can contribute to a better understanding of the virus's pathogenesis, replication mechanisms, and potential therapeutic targets.
In summary, the AffiAB® Goat anti-NSP1 (SARS-CoV-2) Polyclonal IgG Antibody is a valuable tool for scientists studying the SARS-CoV-2 virus. Its specificity and sensitivity make it suitable for various applications in virology, immunology, and COVID-19 research.